Uptake and 4-week quit rates from an opt-out co-located smoking cessation service delivered alongside community-based low-dose computed tomography screening within the Yorkshire Lung Screening Trial
Extract
Low-dose computed tomography (LDCT) screening for lung cancer has been shown to reduce lung cancer-specific mortality in two large, randomised trials [1, 2], and implementation of screening is currently underway in many high- and middle-income countries [3]. Of those people responding to an invitation for lung cancer screening and subsequently eligible, between 30% and 50% are currently smoking [4, 5]. Evidence of the impact of screening alone on smoking cessation rates in randomised trials is mixed. Three studies have compared quit rates in participants randomised to LDCT screening versus a non-screened control group, with one study showing an increased quit rate in the screened group [6], one study showing no difference between screened and non-screened participants [7], and one study showing a higher quit rate in non-screened participants, although this effect did not persist after intention-to-treat analysis [8]. Importantly, smoking cessation interventions were minimal in all three studies, comprising signposting to existing services, written information to support quit attempts and (in one study) very brief advice [6–8].
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Murray, R. L., Alexandris, P., Baldwin, D., Brain, K., Britton, J., Crosbie, P. A. J., Gabe, R., Lewis, S., Parrott, S., Quaife, S. L., Tam, H. Z., Wu, Q., Beeken, R., Copeland, H., Eckert, C., Hancock, N., Lindop, J., McCutchan, G., Marshall, C., Neal, R Tags: COPD and smoking Original Articles: Smoking cessation Source Type: research
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Chronic Obstructive Pulmonary | CT Scan | Lung Cancer | Neurology | Respiratory Medicine | Smokers | Study